Citations

Showing 10 of 108152 citations.

HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
Guerrero, Carlo , Jain, Tania , Kelemen, Katalin, Jain, Tania

Mayo Clinic

Case Reports in Hematology | August 22, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-6

10.1155/2019/4536157 | PMID 31534804 Get It

Human herpesvirus 8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus, is a DNA oncovirus known for its role in the development of Kaposi’s sarcoma (KS) and several lymphoproliferative disorders (LPDs). HHV-8 promotes lymphoproliferation via the activation of the interleukin-6 receptor signaling pathway, as well as a host of other regulatory mechanisms. The spectrum of HHV-8-associated LPDs is increasing. The World Health Organization has recently updated the classification of HHV-8-associated LPDs by introducing HHV-8-positive germinotropic LPD (GLPD) in addition to the previously recognized entities of HHV-8-positive diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), primary effusion lymphoma (PEL), and HHV-8-positive multicentric Castleman’s disease (MCD). We present here a case of an HIV-positive woman with a history of KS, who later developed three HHV-8-associated LPDs, including HHV-8-positive MCD, PEL, and GLPD. To the best of our knowledge, this is the first reported case of a patient with this combination of individually rare HHV-8-associated LPDs. This case illustrates the spectrum and the sequential development of the different clinical manifestations of HHV-8-associated diseases. Detection of HHV-8 can have clinical significance in the diagnosis and management of certain HHV-8-associated conditions. Recently discovered variants of HHV-8-associated LPDs indicate that this group represents a diverse spectrum of disorders, whose classification may require further refinement beyond the currently recognized entities.
Iron deficiency anemia associated with extracorporeal photopheresis: A retrospective analysis
Bartoo, Gabriel , Dierkhising, Ross , Mara, Kristin C. , Patnaik, Mrinal M. , Gastineau, Dennis A. , Adamski, Jill , Merten, Julianna A., Kuhn, Alexis K, Bartoo, Gabriel T , Dierkhising, Ross A, Mara, Kristin C , Kuhn, Alexis , Winters, Jeffrey L.

Mayo Clinic

Journal of Clinical Apheresis | August 22, 2019 | Volume: 34 | Issue: 6 | Pages: 666-671

10.1002/jca.21744 | PMID 31436854 Get It

AbstractBackgroundExtracorporeal photopheresis (ECP) is associated with few adverse effects. We have anecdotally noted patients treated with long‐term ECP develop iron deficiency anemia (IDA).MethodsWe performed a retrospective chart review of adult patients who received ECP for any indication at Mayo Clinic Rochester and Mayo Clinic Arizona. The primary objective was to describe the cumulative incidence of IDA at 1 year of ECP therapy.ResultsA total of 123 patients were eligible for analysis. Graft‐vs‐host disease was the most common indication for ECP (n = 76, 61.8%). At 1 year of ECP therapy, the cumulative incidence of IDA was 24.1% (95% CI, 14.2%‐32.9%). At 5 years, the cumulative incidence of IDA was 68.3% (95% CI, 38%‐83.8%). Risk factors for the development of IDA included: cumulative number of ECP sessions (HR 1.34, 95% CI, 1.05‐1.73 per 10 additional sessions, P = .022), an indication for ECP of solid organ transplant rejection (compared to cutaneous T‐cell lymphoma, HR 5.46, 95% CI, 2.06‐14.49, P < .001), and proton pump inhibitor use at baseline (HR 2.15, 95% CI, 1.1‐4.21, P = .03). Iron supplementation was initiated in 29 of 37 evaluable patients who developed IDA, with a cumulative incidence of supplementation in 77.2% patients within 3 months of recognition of IDA (95% CI, 55.8%‐88.3%). Hemoglobin normalized in 50.1% of patients started on iron supplementation for IDA within 7 months (95% CI, 25.2%‐66.7%).ConclusionsIron deficiency anemia is common in patients receiving long‐term ECP and occurs throughout ECP therapy. IDA resolved with iron supplementation in half of patients.
Nonoperative Management of Minimally Displaced Patellar Sleeve Fractures
Sousa, Paul L., Prince, Matthew, Dahm, Diane L., Prince, Matthew R, Stuart, Michael J.

Mayo Clinic

The Journal of Knee Surgery | August 21, 2019 | Volume: 34 | Issue: 03 | Pages: 242-246

10.1055/s-0039-1694742 | PMID 31434147 Get It

AbstractPatellar sleeve fractures primarily occur in the adolescent population from a rapid contraction of the quadriceps with the knee in a flexed position. Several small case reports describe operative reduction and fixation for displaced fractures. However, there is sparse literature on nonoperative management of these injuries. Retrospective review and prospective follow-up of all patients diagnosed with patellar sleeve fracture between 1991 and 2014 at a single institution. Patients with superior pole avulsion fractures, history of prior knee surgery, and fractures managed operatively were excluded. Patients with a clinical diagnosis without support of advanced imaging were also excluded. Radiographs and magnetic resonance imaging (MRI) were reviewed for initial fracture displacement, time until fracture union, and the presence of patellar tendon ossification. Outcome was assessed using the Tegner's activity scale, Kujala's Score and the International Knee Documentation Committee (IKDC) subjective knee evaluation score at final follow-up. Eighteen nonoperatively treated distal patellar pole sleeve fractures were identified, while five patients had advanced imaging to support their diagnosis. All were males with a mean age of 15.1 (range: 12–18). Traumatic and sport-related injuries were noted in the majority of patients. Only one patient had any appreciable displacement, but still < 2 mm. Final radiographic evaluation revealed fracture healing without patellar tendon ossification in all patients. All five patients had full terminal knee extension and symmetric range of motion. Mean IKDC score was 96.4 (range: 82–100) mean Tegner's activity score was 60 (range: 5–8), and mean Kujala's score was 89.7 (range: 63–100) at final follow-up. Of the five cases, three patients presented in a delayed fashion, and all went on to have surgical treatment. Two required arthroscopic loose body removal, while the other had an open patellar debridement and platelet-rich plasma (PRP) injection. Minimally displaced patellar sleeve fractures can be successfully managed nonoperatively with excellent clinical outcomes. However, delayed in presentation may be associated with worse outcome. This study of case series reflects level of evidence IV.
Functional MRI for evaluation of hyaline cartilage extracelullar matrix, a physiopathological-based approach
Martín‐Noguerol, Teodoro , Raya, José G. , Wessell, Daniel E. , Vilanova, Joan C. , Rossi, Ignacio , Luna, Antonio

Mayo Clinic

The British Journal of Radiology | August 21, 2019 | Volume: 92 | Issue: 1103 | Pages: 20190443

10.1259/bjr.20190443 | PMID 31433668 Get It

MRI of articular cartilage (AC) integrity has potential to become a biomarker for osteoarthritis progression. Traditional MRI sequences evaluate AC morphology, allowing for the measurement of thickness and its change over time. In the last two decades, more advanced, dedicated MRI cartilage sequences have been developed aiming to assess AC matrix composition non-invasively and detect early changes in cartilage not captured on morphological sequences. T2-mapping and T1ρ sequences can be used to estimate the relaxation times of water inside the AC. These sequences have been introduced into clinical protocols and show promising results for cartilage assessment. Extracelullar matrix can also be assessed using diffusion-weighted imaging and diffusion tensor imaging as the movement of water is limited by the presence of extracellular matrix in AC. Specific techniques for glycosaminoglycans (GAG) evaluation, such as delayed gadolinium enhanced MRI of cartilage or Chemical Exchange Saturation Transfer imaging of GAG, as well as sodium imaging have also shown utility in the detection of AC damage. This manuscript provides an educational update on the physical principles behind advanced AC MRI techniques as well as a comprehensive review of the strengths and weaknesses of each approach. Current clinical applications and potential future applications of these techniques are also discussed.
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
Sakae, Nobutaka, Josephs, Keith A. , Murray, Melissa E. , Duara, Ranjan , Uitti, Ryan J. , Graff-Radford, N. R., Dickson, Dennis W. , Graff-Radford, Neil R, Dickson, Dennis W , Murray, Melissa E , Litvan, Irene , Duara, Ranjan , Wszołek, Zbigniew K.

Mayo Clinic

Movement Disorders | August 21, 2019 | Volume: 34 | Issue: 11 | Pages: 1655-1662

10.1002/mds.27816 | PMID 31433871 Get It

Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by neuronal loss in the extrapyramidal system with pathologic accumulation of tau in neurons and glia. The most common clinical presentation of PSP, referred to as Richardson syndrome, is that of atypical parkinsonism with vertical gaze palsy, axial rigidity, and frequent falls. Although cognitive deficits in PSP are often ascribed to subcortical dysfunction, a subset of patients has dementia with behavioral features similar to the behavioral variant of frontotemporal dementia. In this study we aimed to identify the clinical and pathological characteristics of PSP presenting with frontotemporal dementia. Methods In this study, we compared clinical and pathologic characteristics of 31 patients with PSP with Richardson syndrome with 15 patients with PSP with frontotemporal dementia. For pathological analysis, we used semiquantitative methods to assess neuronal and glial lesions with tau immunohistochemistry, as well image analysis of tau burden using digital microscopic methods. Results We found greater frontal and temporal neocortical neuronal tau pathology in PSP with frontotemporal dementia compared with PSP with Richardson syndrome. White matter tau pathology was also greater in PSP with frontotemporal dementia than PSP with Richardson syndrome. Genetic and demographic factors were not associated with atypical distribution of tau pathology in PSP with frontotemporal dementia. Conclusions The results confirm the subset of cognitive‐predominant PSP mimicking frontotemporal dementia in PSP. PSP with frontotemporal dementia has distinct clinical features that differ from PSP with Richardson syndrome, as well as differences in distribution and density of tau pathology. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Path Toward Proactive Therapy for Patent Ductus Arteriosus
Yamada, Satsuki , Terzic, André

Mayo Clinic

Clinical Pharmacology & Therapeutics | August 21, 2019 | Volume: 106 | Issue: 6 | Pages: 1187-1190

10.1002/cpt.1583 | PMID 31433488 Get It

Postpartum Tobacco Use and Perceived Stress among Alaska Native Women: MAW Phase 4 Study
Koller, Kathryn R. , Hiratsuka, Vanessa Y. , Merritt, Zoe T , Sapp, Flora, Meade, Crystal D , Hughes, Christine A. , Decker, Paul A. , Murphy, Neil J. , Thomas, Timothy K. , Patten, Christi A. , Koller, Kathryn , Hiratsuka, Vanessa , Flanagan, Christie A. , Decker, Paul A.

Mayo Clinic

International Journal of Environmental Research and Public Health | August 21, 2019 | Volume: 16 | Issue: 17 | Pages: 3024

10.3390/ijerph16173024 | PMID 31438550 Get It

Prior research explored reasons for tobacco use among pregnant Alaska Native (AN) women but did not address the postpartum period. This study followed up with AN women one to three years postpartum who had participated in a prenatal smoking cessation intervention study (Motivate Alaska Women (MAW) Phase 3) and had consented to be re-contacted for future studies. Of 47 eligible women, 32 (68%) participated. A semi-structured phone interview was conducted a mean of 2.0 years after delivery (range 1.6–2.8). Measures assessed self-reported tobacco use status in the 12 months after delivery, at 12 months postpartum, and at the time of the interview; reasons for maintaining abstinence, continued use, or relapse; and included the Perceived Stress Scale (PSS) and Negative Affect (NA) scale. Content analysis was used to generate themes from open-ended response items. Tobacco use was reported by 23 women (72%) at delivery, 30 (94%) within the 12 months after delivery, 27 (84%) at 12 months postpartum, and 29 (91%) at the time of the interview. Among nine women not using tobacco at delivery, seven (78%) relapsed during the 12 months after delivery. Of the 29 current tobacco users, 28 (97%) smoked cigarettes. Twenty-seven participants (84%) reported stress and 15 (52%) indicated addiction as reasons for continuing, starting, or resuming tobacco use. Types of stressors were related to parenting and traumatic experiences. Among current tobacco users, mean NA score (18.7) was significantly higher (p = 0.01) than the normative mean (14.8), but no differences were detected for PSS score. In this sample of AN women, postpartum tobacco use was highly prevalent, and stress was a primary reason that women endorsed for using tobacco. These preliminary results have several practice and research implications for exploring ways to support non-tobacco use among postpartum AN women.
Overview for Implementation of Telemedicine Services in a Large Integrated Multispecialty Health Care System
Lokken, Troy G., Blegen, Rebecca N., Hoff, Mekenzie D., Blegen, R Nicole, Demaerschalk, Bart M.

Mayo Clinic

Telemedicine and e-Health | August 21, 2019 | Volume: 26 | Issue: 4 | Pages: 382-387

10.1089/tmj.2019.0079 | PMID 31433261 Get It

This article reviews a systematic approach to implementation of telemedicine services in a large integrated multispecialty health care system. Eight components of operational infrastructure have been identified as essential to effective program deployment and sustainability. These components include (1) dedicated telemedicine staffing infrastructure, (2) functional support partnerships, (3) standardized systems of deployment, (4) refined operational processes and procedures, (5) data analytics, (6) practice partnerships, (7) performance reporting, and (8) provider instruction. Mayo Clinic Center for Connected Care endeavors to share its practice and its learning.